Clinical Trials Directory

Trials / Completed

CompletedNCT04396210

Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic

Status
Completed
Phase
Study type
Observational
Enrollment
389 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years – 47 Years
Healthy volunteers
Not accepted

Summary

The COVID-19 pandemic brought new challenges to our nationwide healthcare system, with rapid escalation of the number of affected individuals over a handful of weeks. From March 13, a first set of measures was taken to minimise the spread of the virus, which largely impacted societal and economical daily life. A view days later, on March 17, the country was put in "lockdown" and all non-urgent medical treatments were cancelled or postponed. As recommended by the major scientific fertility societies, all non-ivf fertility treatments were discontinued abruptly, whereas started ivf stimulations were continued until oocyte aspiration, where after a freeze-all strategy was applied. There is little information available for women aiming for pregnancy or embarking on assisted conception. Given the modelling of the pandemic, including the time to peak and subsequent tail, considerable delays in conception to substantially attenuate risk may be required, which will inevitably impact patients wellbeing and overall success rates. A questionnaire was developed to explore patients perspectives on different aspects of their fertility treatment during the COVID-19 pandemic. The questionnaire contains the following sections: * demographic variables; * questions regarding the fertility history of the respondent; * questions regarding the impact of fertility treatment cancellation / postponing fertility treatment during COVID-19 on their life, psychological wellbeing and relationship; * questions regarding continuing medical treatment on their own, or seeking treatment elsewhere; * questions regarding the satisfaction of measures taken by their fertility center regarding the COVID-19 pandemic; * questions regarding expectations of further treatments, with focus on safety issues related to the COVID-19 pandemic. Eligible patients will be selected electronically from our database and digital agenda. After selection, patients will be contacted via email to participate. Two reminders will be send in case the questionnaire is not filled out: a first reminder after one week, a second reminder after two weeks.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireEligible patients will be selected electronically from our database and digital agenda. After selection, patients will be contacted via email to participate. Two reminders will be send in case the questionnaire is not filled out: a first reminder after one week, a second reminder after two weeks.

Timeline

Start date
2020-05-14
Primary completion
2020-06-18
Completion
2020-06-18
First posted
2020-05-20
Last updated
2020-11-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04396210. Inclusion in this directory is not an endorsement.

Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic (NCT04396210) · Clinical Trials Directory